The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kuznetsova N.E.

Tyumen State Medical University;
Regional Clinical Hospital No. 2

Kuznetsova T.B.

Tyumen State Medical University

The combination of recurrent otitis media and adenotomy in early childhood as diagnostic marker of mucopolysaccharidosis type II (Hunter syndrome)

Authors:

Kuznetsova N.E., Kuznetsova T.B.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2022;87(4): 19‑22

Read: 2194 times


To cite this article:

Kuznetsova NE, Kuznetsova TB. The combination of recurrent otitis media and adenotomy in early childhood as diagnostic marker of mucopolysaccharidosis type II (Hunter syndrome). Russian Bulletin of Otorhinolaryngology. 2022;87(4):19‑22. (In Russ.)
https://doi.org/10.17116/otorino20228704119

Recommended articles:

References:

  1. Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology. 2011;50(Suppl 5):4-12.  https://doi.org/10.1093/rheumatology/ker394
  2. Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlschütter A, Kampmann C, Beck M. Cumulative incidence rates of the mucopolysaccharidoses in Germany. Journal of Inherited Metabolic Disease. 2005;28(6):1011-1017. https://doi.org/10.1007/s10545-005-0112-z
  3. Patel P, Suzuki Y, Maeda M, Yasuda E, Shimada T, Orii KE, Orii T, Tomatsu S. Growth charts for patients with Hunter syndrome. Molecular Genetics and Metabolism Reports. 2014;1:5-18.  https://doi.org/10.1016/j.ymgmr.2013.10.001
  4. Wraith JE, Scarpa M, Beck M, Bodamer OA, de Meirleir L, Guffon N, Meldgaard Lund A, Malm G, van der Ploeg AT, Zeman J. Mucopolysaccharidosis type II (Hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics. 2008;167(3):267-277.  https://doi.org/10.1007/s00431-007-0635-4
  5. Mendelsohn NJ, Harmatz P, Bodamer O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R; Hunter Outcome Survey Investigators. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genetics in Medicine. 2010;12(12):816-822.  https://doi.org/10.1097/gim.0b013e3181f6e74d
  6. Gönüldaş B, Yılmaz T, Sivri HS, Güçer KŞ, Kılınç K, Genç GA, Kılıç M, Coşkun T. Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway. International Journal of Pediatric Otorhinolaryngology. 2014;78(6):944-949.  https://doi.org/10.1016/j.ijporl.2014.03.021
  7. Wraith JE, Scarpa M, Beck M, Bodamer OA, de Meirleir L, Guffon N, Meldgaard Lund A, Malm G, van der Ploeg AT, Zeman J. Mucopolysaccharidosis type II (Hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics. 2008;167(3):267-277.  https://doi.org/10.1007/s00431-007-0635-4
  8. Grupo de Trabajo de Enfermedades poco frecuentes [Guideline for diagnosis, follow-up and treatment of mucopolysaccharidoses type II or Hunter disease]. Archivos Argentinos de Pediatria. 2011;109(2):175-181. (In Spanish).
  9. Morimoto N, Kitamura M, Kosuga M, Okuyama T. CT and endoscopic evaluation of larynx and trachea in mucopolysaccharidoses. Molecular Genetics and Metabolism. 2014;112(2):154-159.  https://doi.org/10.1016/j.ymgme.2014.03.013
  10. Scarpa M, Almássy Z, Beck M, Bodamer O, Bruce IA, de Meirleir L, Guffon N, Guillén-Navarro E, Hensman P, Jones S, Kamin W, Kampmann C, Lampe C, Lavery CA, Teles EL, Link B, Lund AM, Malm G, Pitz S, Rothera M, Stewart C, Tylki-Szymańska A, van der Ploeg A, Walker R, Zeman J, Wraith JE; Hunter Syndrome Europena Expert Council. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet Journal of Rare Diseases. 2011;6:72.  https://doi.org/10.1186/1750-1172-6-72
  11. Valayannopoulos V, Wijburg FA. Therapy for the mucopolysaccharidoses. Rheumatology. 2011;50(Suppl 5):49-59.  https://doi.org/10.1093/rheumatology/ker396
  12. Torres DA, Barth AL, Valente MPM, Mello PP, Horovitz DDG. Otolaryngologists and the Early Diagnosis of Mucopolysaccharidoses: A Cross-Sectional Study. Diagnostics. 2019;9(4):187.  https://doi.org/10.3390/diagnostics9040187
  13. Lin HY, Chuang CK, Lee KS, Lin SP. Awareness of Mucopolysaccharidosis in an Otorhinolaryngologic Clinic. Pediatrics and Neonatology. 2017;58(2):198-199.  https://doi.org/10.1016/j.pedneo.2016.12.004

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.